Videos – Benchmark Products
In the demanding world of pharmaceuticals and life sciences, precision and compliance are critical. Benchmark Products leads the industry by providing high-quality, regulatory-compliant cleanroom solutions. Among those is it’s BioMark Bags™. These single-use bioprocessing bags tailored for the pharmaceutical industry, feature Renolit 9101 film for durability and chemical resistance. The bags have a 5-layer structure, offering…
Latest
Benchmark Products
The Bullard Sightline Hood
The Bullard™ Sightline Hood, crafted with Tychem® 2000 material, promises unparalleled comfort and productivity for users in manufacturing suites. Its design boasts features like a sleek profile, a panoramic 320-degree lens, effortless breathing, and a lightweight custom-fit hose that reduces head pressure. Enhanced with a roomy interior, soft sport knit neck cuff, and compatibility…
Health
Benchmark GMP Cleanroom Socks
Benchmark GMP Cleanroom Socks are the ideal solution to keep manufacturing facilities Annex 1 compliant. These socks allow personnel to enter changing rooms leading directly to class B and class C cleanrooms. Additional features include: continuous filament polyester and nylon yarn particulate contamination reduction available in sizes S-2XL
Healthcare
Suite Touchless Mop by Benchmark Products
Benchmark Products’ Suite Touchless Mop is used for pharmaceutical manufacturing cleanrooms. It has an ergonomic handle made of anodized aluminum. This adjustable mop handle length ranges from 39″ to 71″ for hard-to-reach areas. It is for use with Suite Ultra-Fiber mop pads.
Healthcare
Suite Ultra-Fiber Wipers by Benchmark Products
Benchmark Products’ Suite Ultra-Fiber Wipers are used for pharmaceutical manufacturing cleanrooms. These high-performance wipers are engineered to meet the rigorous standards of cleanliness and durability in pharma and life sciences manufacturing. Available in two sizes, the SC6 and SC12 wipers are designed with a textured pattern to enhance surface cleaning capabilities. They are snag-resistant, non-particulating,…
Benchmark Products
Suite Reach Tool with Padded Cover by Benchmark Products
Benchmark Products’ Suite line of products for pharmaceutical cleanroom offers the Suite Reach Tool with Ultra-Fiber cover. This is the essential tool for hard-to-reach or small spaces and is designed primarily for isolators, biological safety cabinets, RABs, glove boxes and other challenging spaces. The tool is made of stainless steel with an anodized aluminum extension…
Benchmark Products
Suite Sponge Mop by Benchmark Products
Benchmark Products’ Suite line of products for pharmaceutical cleanroom offers the Suite Ultra-Fiber Sponge for cleaning and disinfecting difficult objects and equipment. The core of the sponge is comprised of polyurethane foam for a soft and absorbent surface. The Suite Sponge also has a revolutionary cover of Suite Ultra-Fiber, which is a micro-denier non-particulating fiber…
Latest
Analyzing the Suppressive TME in In Vitro Based Assays
In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…
Targeting T Cells Within the Cancer Immunity Cycle
As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…
Inside Oncology Drug Development: Overcoming Resistance with Science
In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…
